• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Education
  • Events
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs
  • Business Directory

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

Health screening programmes suspended in Scotland

30th March 2020 by PIP editor Leave a Comment

 

Scottish Government is to temporarily pause a number of screening programmes due to the rapidly evolving situation with COVID-19.

 

In practice, this means no additional patients will be invited for screening until further notice. Results for those who have recently been screened or who have completed and returned home test kits will continue to be processed.

 

The move means healthcare staff can be re-allocated to support other essential services, including COVID-19 laboratory testing and covering for colleagues who are unwell or self-isolating.

 

The paused programmes are as follows:

 

  • Breast Screening (mammograms)
  • Cervical Screening (smear tests)
  • Bowel Screening (home test kits)
  • Abdominal Aortic Aneurysm (AAA) Screening (ultrasound of abdomen)
  • Diabetic Retinopathy (Eye) Screening (images taken of the eye).

 

Pregnancy and Newborn Screening Programmes, including tests offered during pregnancy and just after birth, will continue where logistically practical.

 

Public Health Minister Joe FitzPatrick said:

 

“This has been a difficult decision to take, but it is important to be aware that these screening programmes are focused on a well population, who are not known to have the conditions they are screened for.

 

“I want members of the public to be assured we will restart screening programmes as soon as it is safe to do so following clinical advice. When this happens invitations will be re-issued and appointments will be rearranged.

 

“In the meantime, it is absolutely vital for patients in between screening appointments or awaiting a rescheduled appointment to be aware of any symptoms or signs of the conditions screened for. Anyone having these symptoms should contact their GP practice.”

 

Chief Medical Officer Catherine Calderwood added:

 

“While there are risks to individuals through delayed diagnosis of conditions that these screening programmes would have picked up, these risks need to be weighed up in the context of the pressures on the NHS in Scotland posed by Covid-19 and balanced against other difficult decisions we will need to make.

 

“The programmes will be potentially fragile due to staff absences and there are clear risks to patients in being asked to attend for screening. The redeployment of staff to work in other areas is also valuable as part of our national effort to tackle the effects of COVID-19.”

 

 

This circular is being shared under the Open Government Copyright licence.

 

 

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Related

Next article  GPhC publish new pharmacist education and training standards

Filed Under: COVID-19, News Tagged With: Coronavirus, PIP news

Register for our upcoming webinar and live Q&A

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Categories

Follow Us

  • Twitter
  • LinkedIn
  • Facebook
  • Instagram
  • Twitter

PIP business directory

Letters to the editor

Letters to the editor

No national Scottish pharmacy flu service a missed opportunity

The ‘ART’ of Scottish community pharmacy is all about data

All over the counter opiates should be made prescription only

We need to talk about alcoholism in pharmacy

More letters to the editor here...

Blogs

💊 PIP live pharmacy blog

Winter stresses must not ‘destabilise’ general practice

What is it like to depend on medicine to treat endometriosis?

Opinion

Why is pharmacy not integral to government mass vaccination plans?

Pharmacy Covid-19 vaccination involvement is a ‘no-brainer’

The great patient medication returns debacle

CPD Challenges

💊 CPD Challenge: How well do you understand pulmonary embolisms?

💊 CPD Challenge: Prescribing and dispensing clozapine

💊 CPD Challenge: Oral anticoagulants – Dabigatran

More CPD challenges here...

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.